Rua Bioscience Half Year Results data

Results announcement



Results for announcement to the market
Name of issuer Rua Bioscience Limited
Reporting Period 6 months to 31 December 2024
Previous Reporting Period 6 months to 31 December 2023
Currency NZD
Amount (000s) Percentage change
Revenue from continuing operations $889 529%
Total Revenue $889 529%
Net profit/(loss) from continuing
operations
($1,802) 83%
Total net profit/(loss) ($1,802) 83%
Interim/Final Dividend
Amount per Quoted Equity Security Not proposing to pay a dividend
Imputed amount per Quoted Equity
Security
Not Applicable
Record Date Not Applicable
Dividend Payment Date Not Applicable
Current period Prior comparable period
Net tangible assets per Quoted
Equity Security
$0.02 $0.05
A brief explanation of any of the
figures above necessary to enable
the figures to be understood
Refer unaudited interim financial statements
Authority for this announcement
Name of person

authorised to make
this announcement
Paul Naske
Contact person for this
announcement
Paul Naske
Contact phone number +64 (21) 445 154
Contact email address paul.naske@ruabio.com
Date of release through MAP

28 February 2025

Unaudited financial statements accompany this announcement.